which tirzepatide is for weight loss vs. Semaglutide Tirzepatide Injections for Medical Weight

Additionally, as seen in IIH, the abrupt discontinuation of GLP-1RAs may lead to symptom exacerbation, raising concerns about potential dependency

Awasthi et al., 2005

22 In the type 2 diabetes cohort, the cumulative incidence was 8.9% for those treated with semaglutide and 1.8% for those treated with non-GLP-1 agonists

[18] [19] Whilst these benefits likely result from multiple mechanismsincluding weight loss, blood pressure reduction, and anti-inflammatory effectsimprovements in lipid profiles may contribute to the overall cardiovascular protection observed

Nussbaum RL, Ellis CE

Why is phentermine described as short-term while semaglutide is not